Shanghai Junshi Biosciences Co., Ltd. (HKG:1877)
Hong Kong · Delayed Price · Currency is HKD 22.54
+1.34 (6.32%)
At close: Mar 27, 2026
HKG:1877 Market Cap
HKG:1877 has a market cap or net worth of 35.08 billion as of March 27, 2026. Its market cap has increased by 25.03% in one year.
Market Cap
35.08B
Enterprise Value
36.14B
Revenue
2.78B
Ranking
n/a
PE Ratio
n/a
Stock Price
22.54
Market Cap Chart
Since December 24, 2018, HKG:1877's market cap has increased from 18.06B to 35.08B, an increase of 94.27%. That is a compound annual growth rate of 9.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 35.08B | 1.22% |
| Dec 31, 2025 | 34.66B | 39.72% |
| Dec 31, 2024 | 24.81B | -37.28% |
| Dec 29, 2023 | 39.55B | -38.85% |
| Dec 30, 2022 | 64.67B | -7.04% |
| Dec 31, 2021 | 69.57B | -9.43% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 24, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| RemeGen | 68.68B |
| 3SBio | 59.89B |
| Biocytogen Pharmaceuticals (Beijing) | 41.27B |
| Shanghai Henlius Biotech | 38.97B |
| TransThera Sciences (Nanjing) | 27.89B |
| InnoCare Pharma | 26.41B |
| Duality Biotherapeutics | 25.62B |
| Genscript Biotech | 24.27B |